Ovarian stromal hyperthecosis

Cover Page

Cite item

Full Text

Abstract

The review analyzes the data on pathogenesis, prevalence, pathomorphology, clinical manifestations, diagnosis and treatment of ovarian stromal hyperthecosis. This condition is characterized by severe hyperandrogenism and impaired glucose tolerance, and it is mostly occurs in postmenopausal women. Main cause of androgenic hyperproduction in women of reproductive age - the polycystic ovary syndrome - is thoroughly studied; standards for diagnostics and treatment for such patients are developed. Little is known about stromal hyperthecosis, which is a more rare cause of hyperandrogenism that had been considered as a severe form of polycystic ovary syndrome. However, it became an independent nosological form after a detailed study of the pathomorphology. Currently, there are no generally accepted diagnostic criteria for stromal hyperthecosis. This is not only because the disease is rare, but also due to the difficulty of making the final diagnosis. Patients with stromal hyperthecosis are at high risk for developing malignancies - endometrial cancer or breast cancer. So, the need for further investigation and developing treatment approaches is undoubted. In majority of cases, the diagnosis of stromal hyperthecosis is set on histological examination of ovarian tissue from patients with idiopathic severe hyperandrogenism, infertility or cancer. The practicing obstetrician-gynecologist must be aware of this condition to suspect the ovarian stromal hyperthecosis when its typical clinical features manifest, to perform meticulous laboratory and instrumental investigation and to choose the correct management tactics for such patients.

About the authors

A A Khasanov

Kazan State Medical University, Kazan, Russia

V I Zhuravleva

Kazan State Medical University, Kazan, Russia

I O Lipatova

Kazan State Medical University, Kazan, Russia

Email: lipatova90io@gmail.com

References

  1. Калашникова М.Ф., Пищулин A.A., Бронштейн М.Э. Стромальный текоматоз яичников (Обзор литературы) // Пробл. эндокринол. - 1996. - №2. - С. 40-48.
  2. Манухин И.Б., Тумилович Л.Г., Геворкян М.А. Гинекологическая эндокринология. Клинические лекции. Руководство для врачей. - М.: ГЭОТАР-Медиа, 2013. - 272 с.
  3. Barth J.H., Jenkins M., Belchetz P.E. Ovarian hyperthecosis, diabetes and hirsuties in post-menopausal women // Clin. Endocrinol. (Oxf.). - 1997. - Vol. 46, N 2. - P. 123-128.
  4. Brown D.L., Henrichsen T.L., Clayton A.C. et al. Ovarian stromal hyperthecosis: sonographic features and histologic associations // J. Ultrasound Med. - 2009. - Vol. 28, N 5. - P. 587-593.
  5. Bühler-Christen A., Tischler V., Diener P.A., Brändle M. New onset alopecia and hirsutism in a postmenopausal women // Gynecol. Endocrinol. - 2009. - Vol. 25, N 5. - P. 324-327.
  6. Chico A., García J.L., Matías-Guiu X. et al. A gonadotrophin dependent stromal luteoma: a rare cause of post-menopausal virilization // Clin. Endocrinol. (Oxf.). - 1995. - Vol. 43, N 5. - P. 645-649.
  7. Crum C.P., Nucci M.R., Lee K.R. et al. Diagnostic gynecology and obstetric pathology. - Philadelphia; PA: Elsevier Saunders, 2011. - 1216 p.
  8. Damodaran S., Mahmood T., Nawroz I., Swaminathan K. Ovarian stromal hyperplasia and hyperthecosis: an unusual case of post-menopausal hirsutism // Eur. J. Obstetr. Gynecol. Reprod. Biol. - 2011. - Vol. 158, N 1. - P. 114-115.
  9. Derksen J., Nagesser S.K., Meinders A.E., van de Velde C.J. Identification of virilizing adrenal tumors in hirsute women // N. Engl. J. Med. - 1994. - Vol. 331, N 15. - P. 968-973.
  10. Friedman C.I., Schmidt G.E., Kim M.H., Powell J. Serum testosterone concentrations in the evaluation of androgen-producing tumors // Am. J. Obstet. Gynecol. - 1985. - Vol. 153, N 1. - P. 44-49.
  11. Goldman J.M., Kapadia L.J. Virilization in a postmenopausal woman due to ovarian stromal hyperthecosis // Postgrad. Med. J. - 1991. - Vol. 67. - P. 304-306.
  12. Hall D.A. McCarthy K.A., Kopans D.B. Sonographic visualization of the normal postmenopausal ovary // J. Ultrasound Med. - 1986. - Vol. 5, N 1. - P. 9-11.
  13. Kaltsas G.A., Mukherjee J.J., Kola B. et al. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women? // Clin. Endocrinol. (Oxf.). - 2003. - Vol. 59, N 1. - P. 34-43.
  14. Kim Y., Marjoniemi V.M., Diamond T. et al. Androgenetic alopecia in a postmenopausal woman as a result of ovarian hyperthecosis // Australas. J. Dermatol. - 2003. - Vol. 44, N 1. - P. 62-66.
  15. Krug E., Berga S.L. Postmenopausal hyperthecosis: functional dysregulation of androgenesis in climacteric ovary // Obstet. Gynecol. - 2002. - Vol. 99, N 5. - P. 893-897.
  16. Kumar V., Abbas A.K., Fausto N., Aster J. Pathologic basis of disease. - Philadelphia, PA: Elsevier Saunders, 2010. - 1472 p.
  17. Manieri C., Di Bisceglie C., Fornengo R. et al. Postmenopausal virilization in a woman with gonadotropin dependent ovarian hyperthecosis // J. Endocrinol. Invest. - 1998. - Vol. 21, N 2. - P. 128-132.
  18. Marcondes J.A., Curi D.D., Matsuzaki C.N. et al. Ovarian hyperthecosis in the context of an adrenal incidentaloma in a postmenopausal woman // Arq. Bras. Endocrinol. Metabol. - 2008. - Vol. 52, N 7. - P. 1184-1188.
  19. Meldrum D.R., Abraham G.E. Peripheral and ovarian venous concentrations of various steroid hormones in virilizing ovarian tumors // Obstet. Gynecol. - 1979. - Vol. 53, N 1. - P. 36-43.
  20. Nagamani M., Stuart C.A. Specific binding sites for insulin-like growth factor I in the ovarian stroma of women with polycystic ovarian disease and stromal hyperthecosis // Am. J. Obstet. Gynecol. - 1990. - Vol. 163, N 6, pt. 1. - P. 1992-1997.
  21. Nagamani M., Hannigan E.V., Dinh T.V., Stuart C.A. Hyperinsulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer // J. Clin. Endocrinol. Metab. - 1988. - Vol. 67, N 1. - P. 144-148.
  22. Nagamani M., Van Dinh T., Kelver M.E. Hyperinsulinemia in hyperthecosis of the ovaries // Am. J. Obstet. Gynecol. - 1986. - Vol. 154, N 2. - P. 384-389.
  23. Pascale M.M., Pugeat M., Roberts M. et al. Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours // Clin. Endocrinol. (Oxf.). - 1994. - Vol. 41, N 5. - P. 571-576.
  24. Pasquali R., Stener-Victorin E., Yildiz B.O. et al. Research in polycystic ovary syndrome today and tomorrow // Clin. Endocrinol. - 2011. - Vol. 74, N 4. - P. 424-433.
  25. Picón M.J., Lara J.I., Sarasa J.L. et al. Use of a long-acting gonadotrophin-releasing hormone analogue in a postmenopausal woman with hyperandrogenism due to a hilus cell tumour // Eur. J. Endocrinol. - 2000. - Vol. 142, N 6. - P. 619.
  26. Robboy S.J., Mutter G.L., Prat J. et al. Pathology of the female reproductive tract. - Philadelphia, PA: Elsevier, 2009. - 904 p.
  27. Rothman M.S., Wierman M.E. How should postmenopausal androgen excess be evaluated? // Clin. Endocrinol. - 2011. - Vol. 75, N 2. - P. 160-164.
  28. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) // Hum. Reprod. - 2004. - Vol. 19, N 1. - P. 41-47.
  29. Rousset P., Gompel A., Christin-Maitre S. et al. Ovarian hyperthecosis on grayscale and color Doppler ultrasound // Ultrasound Obstet. Gynecol. - 2008. - Vol. 32, issue 5. - P. 694-699.
  30. Sasano H., Fukunaga M., Rojas M., Silverberg S.G. Hyperthecosis of the ovary. Clinicopathologic study of 19 cases with immunohistochemical analysis of steroidogenic enzymes // Int. J. Gynecol. Pathol. - 1989. - Vol. 8, N 4. - P. 311-320.
  31. Sherman M.E., Lacey J.V., Buys S.S. et al. Ovarian volume: determinants and associations with cancer among postmenopausal women // Cancer Epidemiol. Biomarkers Prev. - 2006. - Vol. 15, N 8. - P. 1550-1554.
  32. Steingold K.A., Judd H.L., Nieberg R.K. et al. Treatment of severe androgen excess due to ovarian hyperthecosis with a long-acting gonadotropin-releasing hormone agonist // Am. J. Obstet. Gynecol. - 1986. - Vol. 154, N 6. - P. 1241-1248.
  33. Vollaard E.S., van Beek A.P., Verburg F.A. et al. Gonadotropin-releasing hormone agonist treatment in postmenopausal women with hyperandrogenism of ovarian origin // J. Clin. Endocrinol. Metab. - 2011. - Vol. 96, N 5. - P. 1197-1201.

© 2014 Khasanov A.A., Zhuravleva V.I., Lipatova I.O.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.




This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies